EssilorLuxottica SA
EssilorLuxottica SA ESLOY Peers
See (ESLOY) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ESLOY | $139.23 | -1.16% | 126.8B | 47.68 | $2.92 | +1.42% |
| SRTOY | $21.39 | +1.91% | 208.1B | 89.13 | $0.24 | +0.31% |
| ESLOF | $277.77 | -0.88% | 126.9B | 47.56 | $5.84 | +1.39% |
| MECNY | $88.63 | +100.00% | 107.8B | N/A | N/A | N/A |
| SSSGY | $42.11 | -0.94% | 76.7B | 135.84 | $0.31 | +0.41% |
| SOAGY | $48.65 | -1.37% | 76.4B | 156.94 | $0.31 | +0.15% |
| HOCPF | $121.77 | -2.35% | 41.4B | 29.41 | $4.14 | +0.89% |
| HOCPY | $117.60 | -2.86% | 40.5B | 28.54 | $4.12 | +0.44% |
| RSMDF | $23.35 | +6.14% | 28B | 26.24 | $0.89 | +0.86% |
| TRUMF | $18.74 | -4.63% | 27.6B | 34.06 | $0.55 | +0.95% |
Stock Comparison
ESLOY vs SRTOY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, SRTOY has a market cap of 208.1B. Regarding current trading prices, ESLOY is priced at $139.23, while SRTOY trades at $21.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas SRTOY's P/E ratio is 89.13. In terms of profitability, ESLOY's ROE is +0.06%, compared to SRTOY's ROE of +0.05%. Regarding short-term risk, ESLOY is more volatile compared to SRTOY. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs ESLOF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, ESLOF has a market cap of 126.9B. Regarding current trading prices, ESLOY is priced at $139.23, while ESLOF trades at $277.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas ESLOF's P/E ratio is 47.56. In terms of profitability, ESLOY's ROE is +0.06%, compared to ESLOF's ROE of +0.06%. Regarding short-term risk, ESLOY is less volatile compared to ESLOF. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs MECNY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, MECNY has a market cap of 107.8B. Regarding current trading prices, ESLOY is priced at $139.23, while MECNY trades at $88.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas MECNY's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to MECNY's ROE of +0.02%. Regarding short-term risk, ESLOY is more volatile compared to MECNY. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs SSSGY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, SSSGY has a market cap of 76.7B. Regarding current trading prices, ESLOY is priced at $139.23, while SSSGY trades at $42.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas SSSGY's P/E ratio is 135.84. In terms of profitability, ESLOY's ROE is +0.06%, compared to SSSGY's ROE of +0.05%. Regarding short-term risk, ESLOY is more volatile compared to SSSGY. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs SOAGY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, SOAGY has a market cap of 76.4B. Regarding current trading prices, ESLOY is priced at $139.23, while SOAGY trades at $48.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas SOAGY's P/E ratio is 156.94. In terms of profitability, ESLOY's ROE is +0.06%, compared to SOAGY's ROE of +0.05%. Regarding short-term risk, ESLOY is more volatile compared to SOAGY. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs HOCPF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, HOCPF has a market cap of 41.4B. Regarding current trading prices, ESLOY is priced at $139.23, while HOCPF trades at $121.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas HOCPF's P/E ratio is 29.41. In terms of profitability, ESLOY's ROE is +0.06%, compared to HOCPF's ROE of +0.15%. Regarding short-term risk, ESLOY is more volatile compared to HOCPF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs HOCPY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, HOCPY has a market cap of 40.5B. Regarding current trading prices, ESLOY is priced at $139.23, while HOCPY trades at $117.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas HOCPY's P/E ratio is 28.54. In terms of profitability, ESLOY's ROE is +0.06%, compared to HOCPY's ROE of +0.15%. Regarding short-term risk, ESLOY is more volatile compared to HOCPY. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs RSMDF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, RSMDF has a market cap of 28B. Regarding current trading prices, ESLOY is priced at $139.23, while RSMDF trades at $23.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas RSMDF's P/E ratio is 26.24. In terms of profitability, ESLOY's ROE is +0.06%, compared to RSMDF's ROE of +0.25%. Regarding short-term risk, ESLOY is more volatile compared to RSMDF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs TRUMF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, TRUMF has a market cap of 27.6B. Regarding current trading prices, ESLOY is priced at $139.23, while TRUMF trades at $18.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas TRUMF's P/E ratio is 34.06. In terms of profitability, ESLOY's ROE is +0.06%, compared to TRUMF's ROE of +0.07%. Regarding short-term risk, ESLOY is less volatile compared to TRUMF. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs TRUMY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, TRUMY has a market cap of 27.2B. Regarding current trading prices, ESLOY is priced at $139.23, while TRUMY trades at $18.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas TRUMY's P/E ratio is 33.31. In terms of profitability, ESLOY's ROE is +0.06%, compared to TRUMY's ROE of +0.07%. Regarding short-term risk, ESLOY is more volatile compared to TRUMY. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs CLPBY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, CLPBY has a market cap of 22B. Regarding current trading prices, ESLOY is priced at $139.23, while CLPBY trades at $9.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas CLPBY's P/E ratio is 31.10. In terms of profitability, ESLOY's ROE is +0.06%, compared to CLPBY's ROE of +0.27%. Regarding short-term risk, ESLOY is less volatile compared to CLPBY. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs CLPBF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, CLPBF has a market cap of 21.9B. Regarding current trading prices, ESLOY is priced at $139.23, while CLPBF trades at $97.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas CLPBF's P/E ratio is 31.67. In terms of profitability, ESLOY's ROE is +0.06%, compared to CLPBF's ROE of +0.27%. Regarding short-term risk, ESLOY is more volatile compared to CLPBF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs SDMHF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, SDMHF has a market cap of 21.1B. Regarding current trading prices, ESLOY is priced at $139.23, while SDMHF trades at $216.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas SDMHF's P/E ratio is 90.27. In terms of profitability, ESLOY's ROE is +0.06%, compared to SDMHF's ROE of +0.05%. Regarding short-term risk, ESLOY is more volatile compared to SDMHF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs SAUHY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, SAUHY has a market cap of 20.6B. Regarding current trading prices, ESLOY is priced at $139.23, while SAUHY trades at $12.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas SAUHY's P/E ratio is 36.89. In terms of profitability, ESLOY's ROE is +0.06%, compared to SAUHY's ROE of +0.14%. Regarding short-term risk, ESLOY is less volatile compared to SAUHY. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs SAUHF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, SAUHF has a market cap of 20.5B. Regarding current trading prices, ESLOY is priced at $139.23, while SAUHF trades at $128.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas SAUHF's P/E ratio is 37.10. In terms of profitability, ESLOY's ROE is +0.06%, compared to SAUHF's ROE of +0.14%. Regarding short-term risk, ESLOY is less volatile compared to SAUHF. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs SARTF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, SARTF has a market cap of 16.5B. Regarding current trading prices, ESLOY is priced at $139.23, while SARTF trades at $212.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas SARTF's P/E ratio is 135.90. In terms of profitability, ESLOY's ROE is +0.06%, compared to SARTF's ROE of +0.05%. Regarding short-term risk, ESLOY is more volatile compared to SARTF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs SUVPF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, SUVPF has a market cap of 15.4B. Regarding current trading prices, ESLOY is priced at $139.23, while SUVPF trades at $259.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas SUVPF's P/E ratio is 167.11. In terms of profitability, ESLOY's ROE is +0.06%, compared to SUVPF's ROE of +0.05%. Regarding short-term risk, ESLOY is more volatile compared to SUVPF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs OCPNF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, OCPNF has a market cap of 15.2B. Regarding current trading prices, ESLOY is priced at $139.23, while OCPNF trades at $13.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas OCPNF's P/E ratio is 18.75. In terms of profitability, ESLOY's ROE is +0.06%, compared to OCPNF's ROE of +0.10%. Regarding short-term risk, ESLOY is more volatile compared to OCPNF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs FSPKF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, FSPKF has a market cap of 12.9B. Regarding current trading prices, ESLOY is priced at $139.23, while FSPKF trades at $22.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas FSPKF's P/E ratio is 122.22. In terms of profitability, ESLOY's ROE is +0.06%, compared to FSPKF's ROE of +0.10%. Regarding short-term risk, ESLOY is more volatile compared to FSPKF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs SSMXY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, SSMXY has a market cap of 10.5B. Regarding current trading prices, ESLOY is priced at $139.23, while SSMXY trades at $16.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas SSMXY's P/E ratio is 27.96. In terms of profitability, ESLOY's ROE is +0.06%, compared to SSMXY's ROE of +0.09%. Regarding short-term risk, ESLOY is less volatile compared to SSMXY. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs SSMXF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, SSMXF has a market cap of 9.3B. Regarding current trading prices, ESLOY is priced at $139.23, while SSMXF trades at $14.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas SSMXF's P/E ratio is 24.75. In terms of profitability, ESLOY's ROE is +0.06%, compared to SSMXF's ROE of +0.09%. Regarding short-term risk, ESLOY is more volatile compared to SSMXF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs CNVVY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, CNVVY has a market cap of 8B. Regarding current trading prices, ESLOY is priced at $139.23, while CNVVY trades at $15.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas CNVVY's P/E ratio is 42.42. In terms of profitability, ESLOY's ROE is +0.06%, compared to CNVVY's ROE of +0.16%. Regarding short-term risk, ESLOY is more volatile compared to CNVVY. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs CNVVF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, CNVVF has a market cap of 6.4B. Regarding current trading prices, ESLOY is priced at $139.23, while CNVVF trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas CNVVF's P/E ratio is 34.78. In terms of profitability, ESLOY's ROE is +0.06%, compared to CNVVF's ROE of +0.16%. Regarding short-term risk, ESLOY is more volatile compared to CNVVF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs CZMWF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, CZMWF has a market cap of 5.8B. Regarding current trading prices, ESLOY is priced at $139.23, while CZMWF trades at $65.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas CZMWF's P/E ratio is 32.73. In terms of profitability, ESLOY's ROE is +0.06%, compared to CZMWF's ROE of +0.07%. Regarding short-term risk, ESLOY is more volatile compared to CZMWF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs YPHDF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, YPHDF has a market cap of 5.7B. Regarding current trading prices, ESLOY is priced at $139.23, while YPHDF trades at $417.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas YPHDF's P/E ratio is 53.45. In terms of profitability, ESLOY's ROE is +0.06%, compared to YPHDF's ROE of +0.13%. Regarding short-term risk, ESLOY is less volatile compared to YPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs CZMWY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, CZMWY has a market cap of 5.7B. Regarding current trading prices, ESLOY is priced at $139.23, while CZMWY trades at $64.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas CZMWY's P/E ratio is 32.24. In terms of profitability, ESLOY's ROE is +0.06%, compared to CZMWY's ROE of +0.07%. Regarding short-term risk, ESLOY is less volatile compared to CZMWY. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs FLMNF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, FLMNF has a market cap of 5.3B. Regarding current trading prices, ESLOY is priced at $139.23, while FLMNF trades at $62.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas FLMNF's P/E ratio is 30.37. In terms of profitability, ESLOY's ROE is +0.06%, compared to FLMNF's ROE of +0.17%. Regarding short-term risk, ESLOY is more volatile compared to FLMNF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs FLMNY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, FLMNY has a market cap of 5.2B. Regarding current trading prices, ESLOY is priced at $139.23, while FLMNY trades at $12.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas FLMNY's P/E ratio is 30.29. In terms of profitability, ESLOY's ROE is +0.06%, compared to FLMNY's ROE of +0.17%. Regarding short-term risk, ESLOY is more volatile compared to FLMNY. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs ADDLF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, ADDLF has a market cap of 4.9B. Regarding current trading prices, ESLOY is priced at $139.23, while ADDLF trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas ADDLF's P/E ratio is 61.76. In terms of profitability, ESLOY's ROE is +0.06%, compared to ADDLF's ROE of +0.06%. Regarding short-term risk, ESLOY is less volatile compared to ADDLF. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs AHICF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, AHICF has a market cap of 4.4B. Regarding current trading prices, ESLOY is priced at $139.23, while AHICF trades at $16.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas AHICF's P/E ratio is 59.89. In terms of profitability, ESLOY's ROE is +0.06%, compared to AHICF's ROE of +0.07%. Regarding short-term risk, ESLOY is more volatile compared to AHICF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs TEVNF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, TEVNF has a market cap of 3.2B. Regarding current trading prices, ESLOY is priced at $139.23, while TEVNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas TEVNF's P/E ratio is -0.21. In terms of profitability, ESLOY's ROE is +0.06%, compared to TEVNF's ROE of +3.22%. Regarding short-term risk, ESLOY is more volatile compared to TEVNF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs ANSLY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, ANSLY has a market cap of 3B. Regarding current trading prices, ESLOY is priced at $139.23, while ANSLY trades at $83.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas ANSLY's P/E ratio is 25.72. In terms of profitability, ESLOY's ROE is +0.06%, compared to ANSLY's ROE of +0.04%. Regarding short-term risk, ESLOY is more volatile compared to ANSLY. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs SHWGF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, SHWGF has a market cap of 3B. Regarding current trading prices, ESLOY is priced at $139.23, while SHWGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas SHWGF's P/E ratio is 11.02. In terms of profitability, ESLOY's ROE is +0.06%, compared to SHWGF's ROE of +0.09%. Regarding short-term risk, ESLOY is more volatile compared to SHWGF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs ANSLF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, ANSLF has a market cap of 2.6B. Regarding current trading prices, ESLOY is priced at $139.23, while ANSLF trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas ANSLF's P/E ratio is 22.22. In terms of profitability, ESLOY's ROE is +0.06%, compared to ANSLF's ROE of +0.06%. Regarding short-term risk, ESLOY is more volatile compared to ANSLF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs GRRMF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, GRRMF has a market cap of 2.5B. Regarding current trading prices, ESLOY is priced at $139.23, while GRRMF trades at $73.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas GRRMF's P/E ratio is 28.60. In terms of profitability, ESLOY's ROE is +0.06%, compared to GRRMF's ROE of +0.05%. Regarding short-term risk, ESLOY is more volatile compared to GRRMF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs TCHBF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, TCHBF has a market cap of 2.5B. Regarding current trading prices, ESLOY is priced at $139.23, while TCHBF trades at $200.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas TCHBF's P/E ratio is 31.06. In terms of profitability, ESLOY's ROE is +0.06%, compared to TCHBF's ROE of +0.07%. Regarding short-term risk, ESLOY is more volatile compared to TCHBF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs TCGGY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, TCGGY has a market cap of 2.2B. Regarding current trading prices, ESLOY is priced at $139.23, while TCGGY trades at $34.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas TCGGY's P/E ratio is 26.84. In terms of profitability, ESLOY's ROE is +0.06%, compared to TCGGY's ROE of +0.07%. Regarding short-term risk, ESLOY is more volatile compared to TCGGY. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs EKTAY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, EKTAY has a market cap of 2B. Regarding current trading prices, ESLOY is priced at $139.23, while EKTAY trades at $5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas EKTAY's P/E ratio is 86.72. In terms of profitability, ESLOY's ROE is +0.06%, compared to EKTAY's ROE of +0.10%. Regarding short-term risk, ESLOY is less volatile compared to EKTAY. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs EKTAF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, EKTAF has a market cap of 1.8B. Regarding current trading prices, ESLOY is priced at $139.23, while EKTAF trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas EKTAF's P/E ratio is 83.33. In terms of profitability, ESLOY's ROE is +0.06%, compared to EKTAF's ROE of +0.10%. Regarding short-term risk, ESLOY is more volatile compared to EKTAF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs BOEUF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, BOEUF has a market cap of 1.7B. Regarding current trading prices, ESLOY is priced at $139.23, while BOEUF trades at $25.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas BOEUF's P/E ratio is 135.53. In terms of profitability, ESLOY's ROE is +0.06%, compared to BOEUF's ROE of +0.18%. Regarding short-term risk, ESLOY is more volatile compared to BOEUF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs NPRRF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, NPRRF has a market cap of 1.6B. Regarding current trading prices, ESLOY is priced at $139.23, while NPRRF trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas NPRRF's P/E ratio is 44.74. In terms of profitability, ESLOY's ROE is +0.06%, compared to NPRRF's ROE of N/A. Regarding short-term risk, ESLOY is more volatile compared to NPRRF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs TGLVY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, TGLVY has a market cap of 1.5B. Regarding current trading prices, ESLOY is priced at $139.23, while TGLVY trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas TGLVY's P/E ratio is 75.86. In terms of profitability, ESLOY's ROE is +0.06%, compared to TGLVY's ROE of +0.02%. Regarding short-term risk, ESLOY is more volatile compared to TGLVY. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs BITGF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, BITGF has a market cap of 1.2B. Regarding current trading prices, ESLOY is priced at $139.23, while BITGF trades at $14.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas BITGF's P/E ratio is 45.06. In terms of profitability, ESLOY's ROE is +0.06%, compared to BITGF's ROE of +0.06%. Regarding short-term risk, ESLOY is more volatile compared to BITGF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs PBHDF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, PBHDF has a market cap of 1.1B. Regarding current trading prices, ESLOY is priced at $139.23, while PBHDF trades at $19.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas PBHDF's P/E ratio is 12.74. In terms of profitability, ESLOY's ROE is +0.06%, compared to PBHDF's ROE of +0.06%. Regarding short-term risk, ESLOY is more volatile compared to PBHDF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs TDVXF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, TDVXF has a market cap of 1.1B. Regarding current trading prices, ESLOY is priced at $139.23, while TDVXF trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas TDVXF's P/E ratio is 65.63. In terms of profitability, ESLOY's ROE is +0.06%, compared to TDVXF's ROE of +0.39%. Regarding short-term risk, ESLOY is more volatile compared to TDVXF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs KSRBF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, KSRBF has a market cap of 866.4M. Regarding current trading prices, ESLOY is priced at $139.23, while KSRBF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas KSRBF's P/E ratio is 4.87. In terms of profitability, ESLOY's ROE is +0.06%, compared to KSRBF's ROE of +0.03%. Regarding short-term risk, ESLOY is less volatile compared to KSRBF. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs NNCSF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, NNCSF has a market cap of 865.3M. Regarding current trading prices, ESLOY is priced at $139.23, while NNCSF trades at $2.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas NNCSF's P/E ratio is 95.00. In terms of profitability, ESLOY's ROE is +0.06%, compared to NNCSF's ROE of +0.07%. Regarding short-term risk, ESLOY is less volatile compared to NNCSF. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs SHWGY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, SHWGY has a market cap of 788.6M. Regarding current trading prices, ESLOY is priced at $139.23, while SHWGY trades at $2.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas SHWGY's P/E ratio is 11.16. In terms of profitability, ESLOY's ROE is +0.06%, compared to SHWGY's ROE of +0.09%. Regarding short-term risk, ESLOY is more volatile compared to SHWGY. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs SPMXF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, SPMXF has a market cap of 550.3M. Regarding current trading prices, ESLOY is priced at $139.23, while SPMXF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas SPMXF's P/E ratio is -18.00. In terms of profitability, ESLOY's ROE is +0.06%, compared to SPMXF's ROE of -0.05%. Regarding short-term risk, ESLOY is more volatile compared to SPMXF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs SAFLF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, SAFLF has a market cap of 544.4M. Regarding current trading prices, ESLOY is priced at $139.23, while SAFLF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas SAFLF's P/E ratio is 22.50. In terms of profitability, ESLOY's ROE is +0.06%, compared to SAFLF's ROE of +0.00%. Regarding short-term risk, ESLOY is less volatile compared to SAFLF. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs JNDOF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, JNDOF has a market cap of 531M. Regarding current trading prices, ESLOY is priced at $139.23, while JNDOF trades at $22.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas JNDOF's P/E ratio is 47.40. In terms of profitability, ESLOY's ROE is +0.06%, compared to JNDOF's ROE of +0.20%. Regarding short-term risk, ESLOY is less volatile compared to JNDOF. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs HGYMF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, HGYMF has a market cap of 510.1M. Regarding current trading prices, ESLOY is priced at $139.23, while HGYMF trades at $23.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas HGYMF's P/E ratio is 32.86. In terms of profitability, ESLOY's ROE is +0.06%, compared to HGYMF's ROE of +0.02%. Regarding short-term risk, ESLOY is less volatile compared to HGYMF. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs CLHLF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, CLHLF has a market cap of 455.6M. Regarding current trading prices, ESLOY is priced at $139.23, while CLHLF trades at $76.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas CLHLF's P/E ratio is 34.82. In terms of profitability, ESLOY's ROE is +0.06%, compared to CLHLF's ROE of +0.12%. Regarding short-term risk, ESLOY is less volatile compared to CLHLF. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs SAFLY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, SAFLY has a market cap of 449.6M. Regarding current trading prices, ESLOY is priced at $139.23, while SAFLY trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas SAFLY's P/E ratio is 223.00. In terms of profitability, ESLOY's ROE is +0.06%, compared to SAFLY's ROE of +0.00%. Regarding short-term risk, ESLOY is less volatile compared to SAFLY. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs GUERF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, GUERF has a market cap of 281M. Regarding current trading prices, ESLOY is priced at $139.23, while GUERF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas GUERF's P/E ratio is 8.19. In terms of profitability, ESLOY's ROE is +0.06%, compared to GUERF's ROE of N/A. Regarding short-term risk, ESLOY is more volatile compared to GUERF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs TSNLF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, TSNLF has a market cap of 252.4M. Regarding current trading prices, ESLOY is priced at $139.23, while TSNLF trades at $5.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas TSNLF's P/E ratio is 33.06. In terms of profitability, ESLOY's ROE is +0.06%, compared to TSNLF's ROE of +0.21%. Regarding short-term risk, ESLOY is less volatile compared to TSNLF. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs OPSSF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, OPSSF has a market cap of 247.4M. Regarding current trading prices, ESLOY is priced at $139.23, while OPSSF trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas OPSSF's P/E ratio is -26.74. In terms of profitability, ESLOY's ROE is +0.06%, compared to OPSSF's ROE of -0.36%. Regarding short-term risk, ESLOY is more volatile compared to OPSSF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs MCDA Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, MCDA has a market cap of 212M. Regarding current trading prices, ESLOY is priced at $139.23, while MCDA trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas MCDA's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to MCDA's ROE of N/A. Regarding short-term risk, ESLOY is less volatile compared to MCDA. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs EEOIF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, EEOIF has a market cap of 63.4M. Regarding current trading prices, ESLOY is priced at $139.23, while EEOIF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas EEOIF's P/E ratio is -2.42. In terms of profitability, ESLOY's ROE is +0.06%, compared to EEOIF's ROE of N/A. Regarding short-term risk, ESLOY is more volatile compared to EEOIF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs UEEC Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, UEEC has a market cap of 53.5M. Regarding current trading prices, ESLOY is priced at $139.23, while UEEC trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas UEEC's P/E ratio is -20.82. In terms of profitability, ESLOY's ROE is +0.06%, compared to UEEC's ROE of +1.31%. Regarding short-term risk, ESLOY is less volatile compared to UEEC. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs IMTH Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, IMTH has a market cap of 20.3M. Regarding current trading prices, ESLOY is priced at $139.23, while IMTH trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas IMTH's P/E ratio is -1.11. In terms of profitability, ESLOY's ROE is +0.06%, compared to IMTH's ROE of +2.29%. Regarding short-term risk, ESLOY is less volatile compared to IMTH. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs GVDI Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, GVDI has a market cap of 16.2M. Regarding current trading prices, ESLOY is priced at $139.23, while GVDI trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas GVDI's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to GVDI's ROE of +0.00%. Regarding short-term risk, ESLOY is less volatile compared to GVDI. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs OTCFF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, OTCFF has a market cap of 10.8M. Regarding current trading prices, ESLOY is priced at $139.23, while OTCFF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas OTCFF's P/E ratio is -12.50. In terms of profitability, ESLOY's ROE is +0.06%, compared to OTCFF's ROE of +18.74%. Regarding short-term risk, ESLOY is less volatile compared to OTCFF. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs OJSY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, OJSY has a market cap of 9.1M. Regarding current trading prices, ESLOY is priced at $139.23, while OJSY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas OJSY's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to OJSY's ROE of N/A. Regarding short-term risk, ESLOY is less volatile compared to OJSY. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs YBGJ Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, YBGJ has a market cap of 8M. Regarding current trading prices, ESLOY is priced at $139.23, while YBGJ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas YBGJ's P/E ratio is -3.35. In terms of profitability, ESLOY's ROE is +0.06%, compared to YBGJ's ROE of +3.46%. Regarding short-term risk, ESLOY is less volatile compared to YBGJ. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs TUTH Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, TUTH has a market cap of 6.1M. Regarding current trading prices, ESLOY is priced at $139.23, while TUTH trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas TUTH's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to TUTH's ROE of N/A. Regarding short-term risk, ESLOY is more volatile compared to TUTH. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs BLMHF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, BLMHF has a market cap of 5.2M. Regarding current trading prices, ESLOY is priced at $139.23, while BLMHF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas BLMHF's P/E ratio is 1.56. In terms of profitability, ESLOY's ROE is +0.06%, compared to BLMHF's ROE of N/A. Regarding short-term risk, ESLOY is more volatile compared to BLMHF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs CBSC Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, CBSC has a market cap of 5.1M. Regarding current trading prices, ESLOY is priced at $139.23, while CBSC trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas CBSC's P/E ratio is -4.50. In terms of profitability, ESLOY's ROE is +0.06%, compared to CBSC's ROE of +1.52%. Regarding short-term risk, ESLOY is more volatile compared to CBSC. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs PXMVF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, PXMVF has a market cap of 4.6M. Regarding current trading prices, ESLOY is priced at $139.23, while PXMVF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas PXMVF's P/E ratio is -0.17. In terms of profitability, ESLOY's ROE is +0.06%, compared to PXMVF's ROE of N/A. Regarding short-term risk, ESLOY is less volatile compared to PXMVF. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs RSCF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, RSCF has a market cap of 4.6M. Regarding current trading prices, ESLOY is priced at $139.23, while RSCF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas RSCF's P/E ratio is -5.34. In terms of profitability, ESLOY's ROE is +0.06%, compared to RSCF's ROE of +0.08%. Regarding short-term risk, ESLOY is less volatile compared to RSCF. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs ECIA Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, ECIA has a market cap of 3.6M. Regarding current trading prices, ESLOY is priced at $139.23, while ECIA trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas ECIA's P/E ratio is -7.68. In terms of profitability, ESLOY's ROE is +0.06%, compared to ECIA's ROE of -0.33%. Regarding short-term risk, ESLOY is more volatile compared to ECIA. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs NSTGQ Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, NSTGQ has a market cap of 3.3M. Regarding current trading prices, ESLOY is priced at $139.23, while NSTGQ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas NSTGQ's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to NSTGQ's ROE of N/A. Regarding short-term risk, ESLOY is less volatile compared to NSTGQ. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs REMI Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, REMI has a market cap of 419.9K. Regarding current trading prices, ESLOY is priced at $139.23, while REMI trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas REMI's P/E ratio is -2.10. In terms of profitability, ESLOY's ROE is +0.06%, compared to REMI's ROE of -0.08%. Regarding short-term risk, ESLOY is more volatile compared to REMI. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs PDMI Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, PDMI has a market cap of 324.9K. Regarding current trading prices, ESLOY is priced at $139.23, while PDMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas PDMI's P/E ratio is -0.01. In terms of profitability, ESLOY's ROE is +0.06%, compared to PDMI's ROE of +0.19%. Regarding short-term risk, ESLOY is more volatile compared to PDMI. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs WHSI Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, WHSI has a market cap of 182.7K. Regarding current trading prices, ESLOY is priced at $139.23, while WHSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas WHSI's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to WHSI's ROE of +0.84%. Regarding short-term risk, ESLOY is more volatile compared to WHSI. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs QTXB Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, QTXB has a market cap of 118K. Regarding current trading prices, ESLOY is priced at $139.23, while QTXB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas QTXB's P/E ratio is -0.05. In terms of profitability, ESLOY's ROE is +0.06%, compared to QTXB's ROE of +0.00%. Regarding short-term risk, ESLOY is less volatile compared to QTXB. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs CEOS Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, CEOS has a market cap of 88.8K. Regarding current trading prices, ESLOY is priced at $139.23, while CEOS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas CEOS's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to CEOS's ROE of +1.18%. Regarding short-term risk, ESLOY is less volatile compared to CEOS. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs SVSO Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, SVSO has a market cap of 63.8K. Regarding current trading prices, ESLOY is priced at $139.23, while SVSO trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas SVSO's P/E ratio is -0.17. In terms of profitability, ESLOY's ROE is +0.06%, compared to SVSO's ROE of +0.17%. Regarding short-term risk, ESLOY is less volatile compared to SVSO. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs SDCCQ Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, SDCCQ has a market cap of 40.3K. Regarding current trading prices, ESLOY is priced at $139.23, while SDCCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas SDCCQ's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to SDCCQ's ROE of -0.61%. Regarding short-term risk, ESLOY is more volatile compared to SDCCQ. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs LANZ Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, LANZ has a market cap of 27.7K. Regarding current trading prices, ESLOY is priced at $139.23, while LANZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas LANZ's P/E ratio is 1.00. In terms of profitability, ESLOY's ROE is +0.06%, compared to LANZ's ROE of +0.01%. Regarding short-term risk, ESLOY is more volatile compared to LANZ. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs GMVDF Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, GMVDF has a market cap of 26K. Regarding current trading prices, ESLOY is priced at $139.23, while GMVDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas GMVDF's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to GMVDF's ROE of +3.68%. Regarding short-term risk, ESLOY is more volatile compared to GMVDF. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs VSMD Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, VSMD has a market cap of 22.4K. Regarding current trading prices, ESLOY is priced at $139.23, while VSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas VSMD's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to VSMD's ROE of +3.15%. Regarding short-term risk, ESLOY is less volatile compared to VSMD. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs ASFX Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, ASFX has a market cap of 17.5K. Regarding current trading prices, ESLOY is priced at $139.23, while ASFX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas ASFX's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to ASFX's ROE of +0.00%. Regarding short-term risk, ESLOY is more volatile compared to ASFX. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs MDIT Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, MDIT has a market cap of 17.2K. Regarding current trading prices, ESLOY is priced at $139.23, while MDIT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas MDIT's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to MDIT's ROE of -0.99%. Regarding short-term risk, ESLOY is less volatile compared to MDIT. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs INND Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, INND has a market cap of 14.5K. Regarding current trading prices, ESLOY is priced at $139.23, while INND trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas INND's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to INND's ROE of +0.32%. Regarding short-term risk, ESLOY is less volatile compared to INND. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs LFPI Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, LFPI has a market cap of 10.2K. Regarding current trading prices, ESLOY is priced at $139.23, while LFPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas LFPI's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to LFPI's ROE of -4.85%. Regarding short-term risk, ESLOY is less volatile compared to LFPI. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs SECI Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, SECI has a market cap of 9.2K. Regarding current trading prices, ESLOY is priced at $139.23, while SECI trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas SECI's P/E ratio is -0.18. In terms of profitability, ESLOY's ROE is +0.06%, compared to SECI's ROE of -0.00%. Regarding short-term risk, ESLOY is less volatile compared to SECI. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs DGEN Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, DGEN has a market cap of 3.9K. Regarding current trading prices, ESLOY is priced at $139.23, while DGEN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas DGEN's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to DGEN's ROE of +0.05%. Regarding short-term risk, ESLOY is more volatile compared to DGEN. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs BLFE Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, BLFE has a market cap of 1.6K. Regarding current trading prices, ESLOY is priced at $139.23, while BLFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas BLFE's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to BLFE's ROE of +0.00%. Regarding short-term risk, ESLOY is more volatile compared to BLFE. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs SEYE Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, SEYE has a market cap of 1.2K. Regarding current trading prices, ESLOY is priced at $139.23, while SEYE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas SEYE's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to SEYE's ROE of N/A. Regarding short-term risk, ESLOY is more volatile compared to SEYE. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs ADLI Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, ADLI has a market cap of 1K. Regarding current trading prices, ESLOY is priced at $139.23, while ADLI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas ADLI's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to ADLI's ROE of +1.36%. Regarding short-term risk, ESLOY is less volatile compared to ADLI. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs HRAL Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, HRAL has a market cap of 396. Regarding current trading prices, ESLOY is priced at $139.23, while HRAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas HRAL's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to HRAL's ROE of +0.13%. Regarding short-term risk, ESLOY is less volatile compared to HRAL. This indicates potentially lower risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs MICRD Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, MICRD has a market cap of 317. Regarding current trading prices, ESLOY is priced at $139.23, while MICRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas MICRD's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to MICRD's ROE of -0.25%. Regarding short-term risk, ESLOY is more volatile compared to MICRD. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs RGBOQ Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, RGBOQ has a market cap of 97. Regarding current trading prices, ESLOY is priced at $139.23, while RGBOQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas RGBOQ's P/E ratio is -0.00. In terms of profitability, ESLOY's ROE is +0.06%, compared to RGBOQ's ROE of N/A. Regarding short-term risk, ESLOY is more volatile compared to RGBOQ. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs BGMD Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, BGMD has a market cap of 11. Regarding current trading prices, ESLOY is priced at $139.23, while BGMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas BGMD's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to BGMD's ROE of +0.00%. Regarding short-term risk, ESLOY is more volatile compared to BGMD. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs VTEQ Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, VTEQ has a market cap of 1. Regarding current trading prices, ESLOY is priced at $139.23, while VTEQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas VTEQ's P/E ratio is -0.00. In terms of profitability, ESLOY's ROE is +0.06%, compared to VTEQ's ROE of N/A. Regarding short-term risk, ESLOY is more volatile compared to VTEQ. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.
ESLOY vs OCPNY Comparison
ESLOY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESLOY stands at 126.8B. In comparison, OCPNY has a market cap of 0. Regarding current trading prices, ESLOY is priced at $139.23, while OCPNY trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESLOY currently has a P/E ratio of 47.68, whereas OCPNY's P/E ratio is N/A. In terms of profitability, ESLOY's ROE is +0.06%, compared to OCPNY's ROE of +0.26%. Regarding short-term risk, ESLOY is more volatile compared to OCPNY. This indicates potentially higher risk in terms of short-term price fluctuations for ESLOY.